540 related articles for article (PubMed ID: 35312115)
21. Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p.
Sun G; Tian J; Xiao Y; Zeng Y
Anticancer Drugs; 2023 Aug; 34(7):816-826. PubMed ID: 36728962
[TBL] [Abstract][Full Text] [Related]
22. The tumor-suppressive function of miR-1 by targeting LASP1 and TAGLN2 in esophageal squamous cell carcinoma.
Du YY; Zhao LM; Chen L; Sang MX; Li J; Ma M; Liu JF
J Gastroenterol Hepatol; 2016 Feb; 31(2):384-93. PubMed ID: 26414725
[TBL] [Abstract][Full Text] [Related]
23. Circ_0008726 promotes malignant progression of ESCC cells through miR-206/HOXA13 pathway.
Han T; Shi M; Chen G; Hao J
Gen Thorac Cardiovasc Surg; 2023 Jan; 71(1):33-45. PubMed ID: 36190650
[TBL] [Abstract][Full Text] [Related]
24. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
[TBL] [Abstract][Full Text] [Related]
25. Circ_0075804 Regulates the Expression of LASP1 by Targeting miR-1287-5p and Thus Affects the Biological Process of Retinoblastoma.
Han Q; Ma L; Shao L; Wang H; Feng M
Curr Eye Res; 2022 Jul; 47(7):1077-1086. PubMed ID: 35285372
[TBL] [Abstract][Full Text] [Related]
26. Knockdown of circular RNA circ-FARSA restricts colorectal cancer cell growth through regulation of miR-330-5p/LASP1 axis.
Lu C; Fu L; Qian X; Dou L; Cang S
Arch Biochem Biophys; 2020 Aug; 689():108434. PubMed ID: 32473899
[TBL] [Abstract][Full Text] [Related]
27. Circular RNA hsa_circ_0003892 promotes the development of papillary thyroid carcinoma by regulating the miR-326/LASP1 axis.
Han P; Liu J; Zhao Q; Li H; Zhang T; Li B; Niu X
Histol Histopathol; 2023 May; 38(5):585-595. PubMed ID: 36394255
[TBL] [Abstract][Full Text] [Related]
28. Circular RNA circNTRK2 facilitates the progression of esophageal squamous cell carcinoma through up-regulating NRIP1 expression via miR-140-3p.
Chen X; Jiang J; Zhao Y; Wang X; Zhang C; Zhuan L; Zhang D; Zheng Y
J Exp Clin Cancer Res; 2020 Jul; 39(1):133. PubMed ID: 32653032
[TBL] [Abstract][Full Text] [Related]
29. Circ_0030998 Restrains Cisplatin Resistance Through Mediating miR-1323/PDCD4 Axis in Non-small Cell Lung Cancer.
Zhu C; Jiang X; Xiao H; Guan J
Biochem Genet; 2022 Dec; 60(6):2434-2454. PubMed ID: 35460386
[TBL] [Abstract][Full Text] [Related]
30. Circ_0001535 Facilitates Tumor Malignant Progression by miR-485-5p/LASP1 Axis in Colorectal Cancer.
Bai L; Gao Z; Jiang A; Ren S; Wang B
Balkan Med J; 2022 Nov; 39(6):411-421. PubMed ID: 36172827
[TBL] [Abstract][Full Text] [Related]
31. Circ_0048856 competes with ABCC1 for miR-193a-5p/miR-98-5p binding sites to promote the cisplatin resistance and tumorigenesis in lung cancer.
Liu L; Zhang Q; Peng H
J Chemother; 2023 Feb; 35(1):39-52. PubMed ID: 35289739
[TBL] [Abstract][Full Text] [Related]
32. Hsa_circ_0048674 facilitates hepatocellular carcinoma progression and natural killer cell exhaustion depending on the regulation of miR-223-3p/PDL1.
Li S; Chen Z; Zhou R; Wang S; Wang W; Liu D; Li M; Guo T
Histol Histopathol; 2022 Dec; 37(12):1185-1199. PubMed ID: 35187630
[TBL] [Abstract][Full Text] [Related]
33. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
[TBL] [Abstract][Full Text] [Related]
34. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition.
Liang Q; Chu F; Zhang L; Jiang Y; Li L; Wu H
Gut Liver; 2023 May; 17(3):389-403. PubMed ID: 35975639
[TBL] [Abstract][Full Text] [Related]
35. Circular RNA PRMT5 knockdown enhances cisplatin sensitivity and immune response in non-small cell lung cancer by regulating miR-138-5p/MYH9 axis.
Xu Y; Zhao R; Wang H; Jiang J; Wang Z; Wang J; Zhang W; Li M
J BUON; 2021; 26(5):1850-1861. PubMed ID: 34761592
[TBL] [Abstract][Full Text] [Related]
36. Circ_0023984 Facilitates Esophageal Squamous Cell Carcinoma Progression by Regulating miR-433-3p/REV3L Axis.
Li T; Li S
Dig Dis Sci; 2022 Mar; 67(3):892-903. PubMed ID: 33725240
[TBL] [Abstract][Full Text] [Related]
37. Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis.
Wu Y; Xie J; Wang H; Hou S; Feng J
J Clin Lab Anal; 2022 May; 36(5):e24408. PubMed ID: 35396749
[TBL] [Abstract][Full Text] [Related]
38. CircRNA B cell linker regulates cisplatin sensitivity in nonsmall cell lung cancer via microRNA-25-3p/BarH‑like homeobox 2 axis.
Liu Y; Hu Y; Zhao C; Lu Q
Anticancer Drugs; 2023 Jun; 34(5):640-651. PubMed ID: 36602424
[TBL] [Abstract][Full Text] [Related]
39. CircRNA circ_0005273 contributes to the cisplatin resistance of cervical cancer cells by sponging miR-133b.
Wu L; Gao J; Liu S; Jia Y; Li C; Duan L
J Obstet Gynaecol; 2022 Oct; 42(7):3086-3093. PubMed ID: 35861544
[TBL] [Abstract][Full Text] [Related]
40. Circ_0030411 aggravates cisplatin-resistance in non-small cell lung cancer by serving as a miR-495-3p sponge to enhance CCND1 expression.
Zhang J; Cui X; Qu H; Zhang Y
J Chemother; 2023 Oct; 35(6):550-562. PubMed ID: 36591727
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
